BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33976645)

  • 1. Novel Use of Bromelain and Acetylcysteine (BromAc®) for Pleural Involvement in Pseudomyxoma Peritonei.
    Lam AR; Bazzi K; Valle SJ; Morris DL
    Case Rep Oncol; 2021; 14(1):628-633. PubMed ID: 33976645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective Use of Bromelain and Acetylcysteine (BromAc
    Skalkos E; Chen KL; Wijayawardana R; Morris DL
    Anticancer Res; 2023 Oct; 43(10):4735-4738. PubMed ID: 37772592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transhepatic Bromelain and Acetylcysteine for Treatment of Posterior Gastric Pseudomyxoma Peritonei: A Case Report.
    Sun SL; Sarofim M; Morris DL
    Anticancer Res; 2024 May; 44(5):2239-2241. PubMed ID: 38677761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel treatment of bromelain and acetylcysteine (BromAc) in patients with peritoneal mucinous tumours: A phase I first in man study.
    Valle SJ; Akhter J; Mekkawy AH; Lodh S; Pillai K; Badar S; Glenn D; Power M; Liauw W; Morris DL
    Eur J Surg Oncol; 2021 Jan; 47(1):115-122. PubMed ID: 31679953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Treatment of Unresectable Pseudomyxoma Peritonei with Multiple Treatments of Intratumoural Bromelain and Acetylcysteine (BromAc
    Yang J; Glenn D; Lodh S; Valle S; Morris DL
    Case Rep Oncol; 2023; 16(1):1551-1556. PubMed ID: 38074518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bromelain and acetylcysteine (BromAc
    Wen HK; Valle SJ; Morris DL
    Am J Cancer Res; 2023; 13(4):1522-1532. PubMed ID: 37168359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pleural extension of mucinous tumor in patients with pseudomyxoma peritonei syndrome.
    Pestieau SR; Esquivel J; Sugarbaker PH
    Ann Surg Oncol; 2000 Apr; 7(3):199-203. PubMed ID: 10791850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pseudomyxoma peritonei (PMP) secondary to mucinous carcinoma of the ovary: a case study].
    Belhamidi MS; Zorkani Y; Krimou H; Kaoukabi A; Menfaa M; Sakit F; Choho K
    Pan Afr Med J; 2019; 33():283. PubMed ID: 31692896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei and Appendix Tumours.
    Lansom J; Alzahrani N; Liauw W; Morris DL
    Indian J Surg Oncol; 2016 Jun; 7(2):166-76. PubMed ID: 27065707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudomyxoma peritonei (PMP) and its therapy - 20 years experience of a single surgical department.
    Bartoška P; Antoš F; Vítek P; Marx J; Holečková P; Novotný M; Kengbaeva M
    Rozhl Chir; 2020; 99(4):159-166. PubMed ID: 32545978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose Pressurized Intrathoracic Aerosol Chemotherapy (PITAC) as an Alternative Therapy for Pleuropulmonary Involvement in Pseudomyxoma Peritonei.
    Robella M; Vaira M; Borsano A; Mossetti C; DE Simone M
    Anticancer Res; 2018 Feb; 38(2):929-932. PubMed ID: 29374723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraperitoneal BromAc
    Mekkawy AH; Breakeit M; Pillai K; Badar S; Akhter J; Valle SJ; Morris DL
    Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A formulation for in situ lysis of mucin secreted in pseudomyxoma peritonei.
    Pillai K; Akhter J; Chua TC; Morris DL
    Int J Cancer; 2014 Jan; 134(2):478-86. PubMed ID: 23843173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.
    Vaira M; Cioppa T; DE Marco G; Bing C; D'Amico S; D'Alessandro M; Fiorentini G; DE Simone M
    In Vivo; 2009; 23(4):639-44. PubMed ID: 19567401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathologic analysis in 46 patients with pseudomyxoma peritonei syndrome: failure versus success with a second-look operation.
    Yan H; Pestieau SR; Shmookler BM; Sugarbaker PH
    Mod Pathol; 2001 Mar; 14(3):164-71. PubMed ID: 11266521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei Arising from Urachus.
    Liu Y; Ishibashi H; Hirano M; Takeshita K; Mizumoto A; Ichinose M; Nishino E; Kashu I; Yamamoto Y; Sugarbaker PH; Yonemura Y
    Ann Surg Oncol; 2015 Aug; 22(8):2799-805. PubMed ID: 25572681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudomyxoma peritonei: natural history and treatment.
    Mittal R; Chandramohan A; Moran B
    Int J Hyperthermia; 2017 Aug; 33(5):511-519. PubMed ID: 28540829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudomyxoma peritonei in the pleural cavity: report of a case.
    Peek DF; Beets GL
    Dis Colon Rectum; 1999 Jan; 42(1):113-5; discussion 115-6. PubMed ID: 10211530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoreductive surgery plus bicavitary chemohyperthermia as treatment of pseudomixoma peritonei with pleural extension. A case report and review of the literature.
    Saladino E; Famulari C; La Monaca E; Fortugno A; Fleres F; Macrì A
    Ann Ital Chir; 2014; 85(4):372-6. PubMed ID: 25263588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of intraperitoneal administration of BromAc on blood parameters: phase 1 study.
    Ke K; Pillai K; Mekkawy AH; Akhter J; Badar S; Valle SJ; Morris DL
    Discov Oncol; 2021 Aug; 12(1):25. PubMed ID: 35201475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.